Objective: Remodeling of extracellular matrix (ECM) is considered to contribute to progression of left ventricular (LV) remodeling and matrix metalloproteinases (MMPs) play crucial roles in regulation of ECM. Activation of MMPs is observed in systolic heart failure (SHF) and is suggested to be responsible for LV dilatation in SHF. Diastolic heart failure (DHF) that is not associated with LV dilatation is also accompanied with collagen accumulation; however, differences in ECM regulatory system, especially activation of MMPs, between SHF and DHF remain to be clarified. This study was conducted to clarify whether MMPs are activated even in DHF, and if so, to characterize the difference in activation of MMPs between SHF and DHF for identification of a target for the prevention of LV remodeling in SHF. Methods: To exclude effects of differences in underling cardiovascular diseases and genetic background on the comparison between DHF and SHF, we used Dahl salt-sensitive rats fed on high salt diet starting at 7 weeks of age as DHF model and at 8 weeks as SHF model, both of which our laboratory recently developed. Results: LV fibrosis progressed in the DHF and SHF model rats. MMP-2 was activated to the same degree in both rats. Activation of MMP-9 was enhanced in the DHF model rats, but the activity was more enhanced in the SHF rats. Film in situ zymography showed that enhanced gelatinolytic activity appeared only in the mid layer of the LV wall in the DHF rats and throughout the wall in the SHF rats. The distribution of gelatinolytic activity was consistent with that of expression of MMP-9 as assessed in immunohistochemical study. Conclusions: MMP-9 rather than MMP-2 may be involved in LV dilatation in SHF and be a specific target for the prevention of LV remodeling.
1 . Introduction titative and qualitative changes in extracellular matrix (ECM) accompany the development of SHF [6] [7] [8] [9] , and are The death rate for cardiovascular diseases has decreased likely to contribute to LV remodeling [10] [11] [12] . Matrix in the past decades [1, 2] , however, prevalence of heart metalloproteinases (MMPs), an endogenous family of zincfailure is still increasing [3] . Most common heart failure is dependent enzymes, are responsible for regulation of ECM associated with left ventricular (LV) systolic dysfunction and several clinical studies reported activation of MMPs in and dilatation, which is called systolic heart failure (SHF).
association with LV remodeling [13] [14] [15] . Thus, there are Progressive LV dilatation is associated with an increased growing interests in MMPs as novel therapeutic targets for incidence of morbidity and mortality in SHF [4, 5] . Quanthe prevention of LV remodeling. A number of recent community-based epidemiological studies have revealed that 30-40% of cases of heart failure occur without systolic dysfunction [16] [17] [18] . In these scribed previously [20] . LV end-systolic stress was calcupatients diastolic dysfunction is implicated as a major lated as previously described [21] . contributor to heart failure, and this condition has been termed diastolic heart failure (DHF). DHF is accompanied 2 .3. Tissue sampling with progression of ECM accumulation in the absence of LV dilatation [19] . If MMPs are also activated in DHF with Following the echo study and adequate anesthesia, the accumulation of ECM, we cannot simply attribute prolung and the heart were harvested and the lung and the left gression of LV dilatation in SHF to the activation of ventricle were weighed. The LV myocardium was harMMPs.
vested, immediately placed in liquid nitrogen and stored at First, it is required to clarify whether MMPs are 280 8C for the measurement of mRNA levels, hydroxyactivated even in DHF. Second, if so, characterization of proline content and in vitro zymography. LV hydroxythe difference in activation of MMPs between SHF and proline content was measured and the results were calcu-DHF may reveal how MMPs contribute to LV remodeling lated as the hydroxyproline content per wet weight of in SHF. Such data are useful to identify a target for the tissue as previously described [22] . Samples for in situ prevention of LV remodeling. To address these issues zymography and immunohistochemistry were embedded in excluding effects of differences in underling cardiovascular Tissue-Tek O.C.T. compound (Sakura Finetechnical, diseases and genetic background on the comparison beTokyo, Japan) and frozen on dry ice. The LV weight tween DHF and SHF, we used SHF and DHF model rats corrected for body weight was determined as LV mass based on hypertensive heart disease, both of which were index as previously described [20] . recently developed using Dahl salt-sensitive (Dahl-s) rats in our laboratory [20] .
.4. Immunohistochemistry

. Methods
Serial cryostat transverse sections with 4-mm thickness were fixed in acetone for 10 min, air-dried, and stained by This study conforms to the guiding principles of Osaka the indirect immunohistological method as previously University Graduate School of Medicine with regard to described [22] . Tissue sections were treated with 0.3% animal care and to the position of the American Heart H O solution for 10 min to inhibit endogenous peroxidase 2 2 Association on Research Animal Use. activity and then incubated with blocking solution (10% donkey serum, Rockland) followed by 2-h incubation with 2 .1. Study subjects purified rabbit anti-rat MMP-9 polyclonal antibody (1:500 dilution, TP-221P Torrey Pines Biolabs., San Diego, CA, Laboratory chow containing 0.3% sodium chloride was USA) or purified rabbit anti-mouse MMP-2 monoclonal fed to weaning male Dahl-S rats (DIS / Eis, Eisai, Tokyo, antibody (1:40 dilution, F-73 Fuji, Toyama, Japan). After Japan) and switched to laboratory chow containing 8% washing in phosphate buffered saline for 10 min, the sodium chloride at 7 weeks (n56) (DHF model) or at 8 sections were incubated with secondary donkey anti-rabbit weeks (n56) (SHF model). Overt heart failure is deantibody and visualized with 3-amino-9-ethyl carbazole as veloped around 19 weeks in the DHF model rats and substrate (AEC; Merck). The nuclei were stained with around 26 weeks in the SHF model rats [20] . Male Dahl-S hematoxylin and the sections were viewed with a light rats continuously fed on laboratory chow containing 0.3% microscope both at low (320) and high (3100) magnificasodium chloride were used as age-matched control at 19 tions. weeks (n56) and 26 weeks (n56), respectively. Systolic blood pressure was measured during the study protocol with a tail cuff system (BP-98A, Softron, Tokyo, Japan).
.5. Quantification of gene expression
.2. Echo and hemodynamic study
Quantification of mRNA levels of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), TIMP-2, type I The rats were anesthetized with ketamine HCl (50 mg / collagen and type III collagen in the left ventricle was kg) and xylazine HCl (10 mg / kg), and transthoracic echo determined by real-time quantitative PCR with Prism 7700 recordings were obtained around 19 weeks for the DHF Sequence Detector (Perkin-Elmer, Foster, CA, USA) as model rats and their age-matched control rats and around previously described [22, 23] . Sequences of all oligonucleo-26 weeks for the SHF model rats and their age-matched tides used as forward primers, reverse primers and decontrol to determine LV cavity size and wall thickness as tection probes are summarized in Table 1 . To correct the previously described [20] . These schedules were decided efficiency of cDNA synthesis, the amounts of each meaaccording to our previous study [20] . LV endocardial and sured mRNA were divided by the amounts of GAPDH mid-wall fractional shortenings were calculated as demRNA used as internal standards. 2 .6. In vitro gelatin zymography studies films with sections were incubated in a moist chamber at 37 8C for 48 h. After incubation, the specimens were LV myocardial samples were homogenized (20-s bursts) stained in a Coplin jar over 15 min with Amido Black 10B in 1.5 ml of an ice-cold extraction buffer containing (Wako, Osaka, Japan), which diluted with 1.0% solution cacodylic acid (10 mmol / l), NaCl (0.15 mol / l), ZnCl (20 with 70% methanol and 10% acetic acid. These films were mmol / l), NaN (1.5 mmol / l), and 0.01% Triton X-100 then decolored for 20 min with a destaining solution 3 (pH 5.0). The homogenate was then centrifuged (4 8C, containing 1.0% solution with 70% methanol and 10% 3000 rpm for 10 min), and the supernatant decanted and acetic acid. The degraded gelatin was not stained with saved on ice. The protein concentration of the myocardial Amido Black, and areas of gelatinolytic activity were extracts was determined with a standardized colorimetric visualized as white to pale blue area on the blue black assay (Bio-Rad protein assay). The extracted samples were background and detected as brightness [25] . then aliquoted and stored at 280 8C. Zymography was performed using Yagai gel electrophoresis apparatus, 2 .8. Statistics zymogram gels and reagents (Yagai, Yamagata, Japan). The thawed extracts samples on ice were mixed with an Results are expressed as mean values6S.E.M. The equal volume of sample buffer at room temperature for 15 statistical analysis was conducted with a commercially min. A 40-mg amount was loaded onto electrophoretic gels available statistical software (STATVIEW 5.0, SAS Institute, (SDS-PAGE) containing gelatin. The gels were run at 15 Cary, NC, USA). Differences at specific stages among mA / gel through the stacking phase and at 30 mA / gel for groups were assessed using one-way ANOVA and Fisher's the separating phase, maintaining a running buffer temprotected least significant difference test. A probability perature of 4 8C for about 80 min, and then incubated 40 h value of less than 0.05 was considered statistically signifiat 37 8C in zymogram developing buffer. Areas of MMP cant. digestion were visualized by negative staining with Coomassie blue. Zymogram gels were digitized with scanner (Studio Scan II si, Agfa, Belgium) set at high-3 . Results resolution. The lysis bands for each sample were determined by quantitative image analysis, and the final 3 .1. Characteristics of the DHF and SHF models results were expressed as pixel density per lane [24] . Each densitometric result was normalized to mean value of Blood pressure steeply elevated from 7 to 13 weeks in control rats at 19 weeks.
the DHF model; thereafter, kept constant at higher level than in the control rats (Fig. 1 ). Blood pressure gradually 2 .7. Film in situ zymography studies increased from 8 to 15 weeks in the SHF model and then remained constant at a higher level than in the control rats. Serial cryostat transverse sections with 4-mm thickness Results of echocardiographic study are shown in Table  were placed on a polyethylene terephthalate base-film 2. LV end-diastolic dimension, LV end-systolic stress and coated with crosslinked gelatin of 7 mm thickness. The endocardial and mid-wall fractional shortenings were not advanced fibrosis in the presence of similar LV hypertrophy.
.2. Gene expression of ECM regulatory systems
The mRNA levels of type I collagen, type III collagen, TIMP-1 and TIMP-2 were significantly elevated in the DHF model rats as compared with the control rats, respectively (Fig. 2) . Gene expression of type I collagen, TIMP-1 and TIMP-2 was significantly enhanced in the SHF model rats as compared with the control rats, and mRNA level of type III collagen also tended to be elevated. As compared with the DHF model rats, mRNA levels of TIMP-1 and TIMP-2 were significantly elevated in the SHF model rats. Gelatin lysis in the region of 92-kDa gelatinase (MMP-9) posterior wall thickness, LV mass index, LV hydroxywas enhanced in both rats; however, it was more promiproline content and a ratio of lung weight to body weight nent in the SHF model rats. were significantly higher in the DHF model rats than in the age-matched control rats. In the SHF model rats, LV endocardial and mid-wall fractional shortenings were 3 .4. Gelatinolytic activities by film in situ zymography significantly decreased and LV end-diastolic dimension was enlarged with increases in LV posterior wall thickness, LV This technique allowed to localize the portions of mass index, LV hydroxyproline content, LV end-systolic gelatinolytic activity in fresh tissue sample (Fig. 4 ). stress and a ratio of lung weight to body weight as Control tissue displayed minimal gelatin digestion. The compared with the control rats.
tissue from the DHF rats showed apparent digestion As compared with the DHF model rats, the SHF model limited to the mid layer in the LV wall. In the SHF model rats were characterized by enlarged LV cavity, increased rats, enhanced gelatinotytic activity was observed through-LV end-systolic stress, depressed LV systolic function and out the wall. 
.5. Immunohistochemical studies
expression and activity of MMP-2 were enhanced to the same degree in both phenotypes of heart failure; however, Immunohistochemical staining for MMP-2 was detected those of MMP-9 were significantly promoted in the SHF throughout the LV wall both in the DHF and SHF model model rats as compared with the DHF model rats. rats (Fig. 5) . In contrast, the expression of MMP-9 was Previous studies demonstrated expression and activity of different between the models: the staining for MMP-9
MMPs were increased in animal models with SHF and in appeared only at the mid layer of the LV wall in the DHF patients with dilated cardiomyopathy [15, 26, 27] . Because model rats and was detected throughout the LV wall in the MMPs are responsible for ECM degradation and remodel-SHF model rats (Fig. 6) . The staining for MMP-2 or ing, the previous studies concluded that the activation of MMP-9 was not apparent in the control rats.
MMPs plays crucial roles in LV dilatation and is therapeutic targets for the prevention of LV remodeling. However, it remains unknown whether all of the activated MMPs 4 . Discussion equally contribute to LV remodeling. Alterations in ECM including collagen accumulation occur in DHF without LV The DHF and SHF model rats with pressure overload dilatation as well as in SHF [19] . Therefore, regulatory showed similar degree of pulmonary congestion as indisystem of ECM may be altered even in DHF, and if so, cated by the data of lung weight. LV hypertrophy and changes in MMP activity observed in SHF may not fibrosis occurred in both models. LV enlargement and necessarily account for LV dilatation. The current study systolic dysfunction were observed in the SHF model rats, demonstrated that activation of MMP-2 occurred in asbut not in the DHF model rats. Progression of whichever sociation with progressive myocardial fibrosis and was phenotype of heart failure was associated with enhanced independent of LV dilatation. In contrast, although MMP-9 gene expression of TIMP-1, TIMP-2, and type I and III was somewhat activated in DHF, its activity was more collagens; however, gene expression of TIMP-1 and enhanced in SHF with LV dilatation. In addition, the TIMP-2 was more upregulated in the SHF model rats. The immunohistochemical study and the in situ zymography demonstrated that region with increased gelatin lysis although the higher LV end-systolic stress in the SHF corresponded to that with increased expression of MMP-9.
model might be a result rather than a cause of LV The current results suggest that MMP-9 rather than MMPdilatation. 2 plays an important role in LV dilatation in hypertensive MMP-9 is inactivated through forming a specific comheart disease. Ducharme et al. [28] reported that LV plex with TIMP-1 [30, 31] , and the predominant enhancedilatation was attenuated even with enhanced expression of ment of gene expression of TIMP-1 in SHF may well lead MMP-2 after myocardial infarction in MMP-9 knockout to the suppression of MMP-9 activity. However, roles of mice. SHF is induced by different causes, and MMP-9 is pro-MMP-9-TIMP-1 complex are complicated. In addilikely to contribute to LV dilatation irrespective of underlytion, TIMP-1 is inactivated by proteinases such as neutroing cardiovascular diseases and may be one of specific phil elastase [30] and MMP-3 affects the formation of therapeutic targets in the prevention of LV remodeling.
pro-MMP-9-TIMP-1 complex and the activity of MMP-9 The reasons why MMP-9 activity was different between [32] . The activity of the proteinases and MMP-3 or the these phenotypes of heart failure in spite of the same amount of the complex was not assessed in the current underlying cardiovascular disease and the same genetic study. Thus, the increased mRNA level of TIMP-1 does background remain to be clarified. Li et al. [29] reported not necessarily correspond to the decrease in MMP-9 downregulation of MMP-9 in patients with dilated caractivity. Recently, TIMP-1 has been shown to exert other diomyopathy following support with LV assist devices.
effects than inhibition of MMPs [33] , and further studies Their study suggested that an increased LV filling pressure are necessary to elucidate roles of TIMP-1 and its effects and hence an elevated LV wall stress are responsible for on MMP-9 activity in heart failure. enhanced expression of MMP-9. In this study, although the MMP-2 was similarly activated in the SHF and DHF data of LV filling pressure were lacking, LV end-systolic models, and its contribution to pathophysiology of these stress was significantly higher in the SHF model than in phenotypes of heart failure remains unclear. A recent the DHF model. Thus, the difference in the wall stress may animal study reported that enhanced activity of MMP-2 be partly responsible for the difference in MMP-9 activity, and MMP-1 was associated with LV diastolic stiffening [34], and MMP-induced stiffening was explained by present there is no established method to assess collagenfacilitated interstitial edema [35] . Chamber stiffness is ase activity, which makes it difficult to clarify mechanisms increased irrespective of phenotype of heart failure when of progressive LV fibrosis in heart failure. LV filling pressure is elevated enough to induce pulmonary congestion. Thus, activated MMP-2 may be partly responsible for chamber stiffening in both DHF and SHF, 5 . Conclusions resulting in elevation of LV filling pressure, pulmonary congestion and overt heart failure.
MMP-2 was activated to the same degree in DHF and Collagen accumulation progressed even though MMP SHF. Activity of MMP-9 was more enhanced in SHF as activity was enhanced in both SHF and DHF models. Gene compared with DHF. Thus, MMP-9 rather than MMP-2 expression of collagen synthesis was also enhanced, and may be responsible for LV dilatation in SHF and a specific thus, collagen production may well overcome activation of target for the prevention of LV remodeling. MMPs and induce imbalance between ECM production and degradation. In both phenotypes of heart failure gene expression of TIMPs was enhanced, and their suppressive A cknowledgements effects on MMP activity might be responsible for insufficient activation of MMPs. However, activation and This study was supported in part by grants from production of other species of MMPs or collagenase Ministry of Health, Labour and Welfare; Ministry of activity was not investigated in this study. Thus, we can Education, Culture, Sports, Science and Technology; raise the possibility that collagenase activity was atTakeda Science Foundation. We are grateful to Ms. tenuated in contrast to enhanced gelatinase activity. At Mayumi Shinzaki for the technical assistance.
